Pharvaris N.V. PHVS
32.02
(0.97)
(2.94%)
as of 25 Sep
- Market cap
- $2.3B
- P/E
- 0.0×
Follow PHVS
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(52.30%) | (66.63%) | (76.21%) | (71.50%) | |
| (48.83%) | (60.57%) | (69.28%) | (64.43%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(49.63%) | (65.02%) | (71.08%) | (57.28%) | |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(2.45) | (2.62) | (2.63) | (2.62) | |
Free Cash Flow |
(152.55) | (155.27) | (171.71) | (178.14) | |
Capital Expenditures |
(0.36) | (0.19) | (0.08) | (0.11) | |
| Other line items | |||||
Cash ROIC |
(20.28%) | (24.32%) | (30.31%) | (24.71%) | |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.01 | 0.01 | 0.01 | 0.01 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.84 | 0.78 | 0.88 | 0.89 | |
Depreciation/Fixed assets |
0.57 | 0.65 | 0.64 | 0.89 | |
Capex/Depreciation |
(0.78) | (0.39) | (0.16) | (0.20) | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(2.44) | (2.62) | (2.63) | (2.62) | |
Capex per Share |
(0.01) | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates